RxDoctor Payments Data

Samuel Pak

Nuclear Medicine · Houston, TXNPI 1821190281

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Viiv Healthcare Company. That places this record below the midpoint for nuclear medicine clinicians in TX, where the typical reported total is $150.

$122in general payments, 2019–2025

Across 1 payment — averaging $121.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$122
$17,209,762in research payments, 2019–2025

Across 138 payments — averaging $124,708 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$9.8M
  • Janssen Research & Development, LLC$6.8M
  • AbbVie$612K

What the payments were for

  • Food & beverage$122100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company1$122

How this compares

$122 in reported general payments places this provider in the 35th percentile of 37 nuclear medicine providers in Texas.

See all nuclear medicine providers in Texas →

Other nuclear medicine in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →